FDA Inspection 1058067 — Virbac Corporation
The FDA completed an inspection of Virbac Corporation on March 22, 2018 in Bridgeton, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Bridgeton, MO (United States)